Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/40060
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_COVID-19TherapeuticApproaches.pdf1,49 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorTrindade, Guilherme G.-
dc.contributor.authorCaxito, Samyra M. C.-
dc.contributor.authorXavier, Alessandra Rejane E. O.-
dc.contributor.authorXavier, Mauro A. S.-
dc.contributor.authorBrandão, Fabiana-
dc.date.accessioned2021-02-11T13:32:59Z-
dc.date.available2021-02-11T13:32:59Z-
dc.date.issued2020-
dc.identifier.citationTRINDADE, Guilherme G. et al. COVID-19: therapeutic approaches description and discussion. Anais da Academia Brasileira de Ciências, Rio de Janeiro, v. 92, n. 2, e20200466, 2020. DOI: https://doi.org/10.1590/0001-3765202020200466. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652020000300902&lng=en&nrm=iso. Acesso em: 11 fev. 2021. Epub June 12, 2020.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/40060-
dc.language.isoInglêspt_BR
dc.publisherAcademia Brasileira de Ciênciaspt_BR
dc.rightsAcesso Abertopt_BR
dc.titleCOVID-19 : therapeutic approaches description and discussionpt_BR
dc.typeArtigopt_BR
dc.subject.keywordAgentes antiviraispt_BR
dc.subject.keywordAntiparasitáriopt_BR
dc.subject.keywordCovid-19pt_BR
dc.subject.keywordSARS-CoV-2pt_BR
dc.subject.keywordTerapêuticapt_BR
dc.rights.license(CC BY)pt_BR
dc.identifier.doihttps://doi.org/10.1590/0001-3765202020200466pt_BR
dc.description.abstract1COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the “Spanish flu” pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date.pt_BR
dc.identifier.orcidhttp://orcid.org/0000-0003-3657-8368pt_BR
dc.identifier.orcidhttp://orcid.org/0000-0002-4266-2964pt_BR
dc.identifier.orcidhttp://orcid.org/0000-0001-8558-4196pt_BR
dc.identifier.orcidhttp://orcid.org/0000-0002-0512-1616pt_BR
dc.identifier.orcidhttp://orcid.org/0000-0001-8358-8062pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins
UnB - Covid-19

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.